1-3 of 3
Thao Tang
Close
Sort by
Journal Articles

Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia

Quy Le, Thao Tang, Amanda Leonti, Sommer Castro, Cyd Nourigat McKay, LaKeisha Perkins, Laura Pardo, Danielle Kirkey, Tiffany Hylkema, Lindsey Call, Makia Manselle, Cristina Abrahams, Kristin Bedard, Arturo Molina, Lisa Eidenshinck Brodersen, Michael R. Loken, Katherine Tarlock, Soheil Meshinchi, Keith R. Loeb
Journal: Blood Advances
Blood Adv (2023) 7 (9): 1666–1670.
https://doi.org/10.1182/bloodadvances.2022008303
Published: 2023
Includes: Supplemental data
Journal Articles

Targeting FOLR1 in high-risk CBF2AT3-GLIS2 pediatric AML with STRO-002 FOLR1–antibody-drug conjugate

Thao Tang, Quy Le, Sommer Castro, Laura Pardo, Cyd Nourigat McKay, LaKeisha Perkins, Jenny Smith, Danielle Kirkey, Cristina Abrahams, Kristin Bedard, Arturo Molina, Lisa Eidenshinck Brodersen, Michael R. Loken, Katherine Tarlock, Soheil Meshinchi, Keith R. Loeb
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5933–5937.
https://doi.org/10.1182/bloodadvances.2022008503
Published: 2022
Includes: Supplemental data
Journal Articles

Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia

Allison J. Kaeding, Sonali P. Barwe, Anilkumar Gopalakrishnapillai, Rhonda E. Ries, Todd A. Alonzo, Robert B. Gerbing, Colin Correnti, Michael R. Loken, Lisa Eidenschink Broderson, Laura Pardo, Quy H. Le, Thao Tang, Amanda R. Leonti, Jenny L. Smith, Cassie K. Chou, Min Xu, Tim Triche, Jr, Steven M. Kornblau, E. Anders Kolb, Katherine Tarlock, Soheil Meshinchi
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2350–2361.
https://doi.org/10.1182/bloodadvances.2021004424
Published: 2021
Includes: Supplemental data